Quick Answer
Pacira BioSciences, Inc. reported Stockholders Equity of $693.11 million for fiscal year 2025.
Pacira BioSciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $693.11M | -11.0% |
| 2024 | $778.35M | -10.5% |
| 2023 | $870.13M | +12.3% |
| 2022 | $775.01M | +6.1% |
| 2021 | $730.41M | +17.9% |
| 2020 | $619.69M | +74.6% |
| 2019 | $354.94M | +10.5% |
| 2018 | $321.23M | +14.9% |
| 2017 | $279.48M | +27.6% |
| 2016 | $218.98M | +0.3% |
| 2015 | $218.39M | +27.6% |
| 2014 | $171.15M | +314.9% |
| 2013 | $41.25M | -37.4% |
| 2012 | $65.86M | +36.4% |
| 2011 | $48.27M | +199.8% |
| 2010 | -$48.38M | -110.8% |
| 2009 | -$22.95M | -406.4% |
| 2008 | $7.49M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $727.21M | -3.0% | -4.0% |
| June 30, 2025 | $757.77M | -13.8% | -5.1% |
| March 31, 2025 | $798.54M | -10.5% | +2.6% |
| December 31, 2024 | $778.35M | -10.5% | +3.8% |
| September 30, 2024 | $749.58M | -9.9% | -14.8% |
| June 30, 2024 | $879.28M | +8.8% | -1.4% |
| March 31, 2024 | $892.16M | +16.2% | +2.5% |
| December 31, 2023 | $870.13M | +12.3% | +4.6% |
- Pacira BioSciences, Inc. showed a decrease of -11.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, Pacira BioSciences, Inc.’s stockholders equity has grown by 9153.8% (from $7.49 million to $693.11 million).
- The most recent figure is from Pacira BioSciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: